N-(Cyclopropylmethyl)-4-{[2-oxo-5-(trifluoromethyl)-1,2-dihydropyridin-1-yl]methyl}benzamide

Catalog No. :
ACLGND870
CAS No. :
339025-15-9
Molecular Formula :
C18H17F3N2O2
Molecular Weight :
350.34

IUPAC Name:N-(cyclopropylmethyl)-4-((2-oxo-5-(trifluoromethyl)pyridin-1(2H)-yl)methyl)benzamide

N-(Cyclopropylmethyl)-4-{[2-oxo-5-(trifluoromethyl)-1,2-dihydropyridin-1-yl]methyl}benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(Cyclopropylmethyl)-4-{[2-oxo-5-(trifluoromethyl)-1,2-dihydropyridin-1-yl]methyl}benzamide
IUPAC NameN-(cyclopropylmethyl)-4-((2-oxo-5-(trifluoromethyl)pyridin-1(2H)-yl)methyl)benzamide
MDL No.MFCD00140133
Molecular FormulaC18H17F3N2O2
Molecular Weight350.34
SMILESO=C(NCC1CC1)C2=CC=C(CN3C=C(C(F)(F)F)C=CC3=O)C=C2
InChI KeyBDRISPFJLMJLJQ-UHFFFAOYSA-N
SynonymN-(CYCLOPROPYLMETHYL)-4-([2-OXO-5-(TRIFLUOROMETHYL)-1(2H)-PYRIDINYL]METHYL)BENZENECARBOXAMIDE;N-(cyclopropylmethyl)-4-{[2-oxo-5-(trifluoromethyl)-1,2-dihydropyridin-1-yl]methyl}benzamide;Benzamide, N-(cyclopropylmethyl)-4-[[2-oxo-5-(trifluoromethyl)-1(2H)-pyridinyl]methyl]-
CAS No.339025-15-9

Synthetic Route by SureRoute

1. ACLGND870 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKYTW152 route compound structure diagram
    ACKYTW1522516-47-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLGND870 route product structure diagram
    ACLGND870339025-15-9
Inquiry

2. ACLGND870 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPVGH896 route compound structure diagram
    ACPVGH89633252-63-0 In Stock
  4. Then
  5. ACLGND870 route product structure diagram
    ACLGND870339025-15-9
Inquiry

Comments (0)